← All trials
NCT04526210
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2020
- Primary completion
- Nov 30, 2020
- Completion date
- Apr 30, 2021
- First posted
- Aug 25, 2020
- Last posted
- Aug 25, 2020
- Enrollment
- 38
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- AlexionLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.